Designing and Sustaining Drug Stability Testing Programs Agenda

Virtual Conference Details

whenWhen?  Tuesday, Sept. 30, 2014
whereWhere? Your Office
whenTime? 10:00 a.m. - 4:00 p.m. EDT
Conference Details


Virtual Conference plus
Audio CD/Transcript
Virtual Conference only $897
24/7 Encore plus CD/Transcript $1297
24/7 Encore Presentation $897
Audio CD/Transcript $897

Designing and Sustaining Drug Stability Testing Programs Agenda

10:00 a.m. – 10:15 a.m.

Introduction to the Virtual Conference

10:15 a.m. – 11:15 a.m.

Session 1
General Stability Considerations Applicable to a Product’s Stability (I.e. Potency), Storage Conditions, Sampling Plan and Sample Handling

Attendees will gain an understanding in the following key areas:

  • Regulatory guidance associated with the requirements of a product’s stability testing program. Delineating the program requirement specific to a type of product.
  • New product stability indicator test, rationale for choosing the test and impact to the product’s shelf life.
  • The relationship between choosing the right product storage temperature and impact to its shelf life.
  • Container Closure Requirements and Storage Temperature for various types of products.
  • Performing an effective sampling plan and utilizing the appropriate sample size for a stability testing program.
  • Performing a compliant sample analysis, handling and effecting the appropriate test specification for the product type.

11:15 a.m. – 11:30 a.m.


11:30 a.m. – 12: 30 p.m.

Session 2
Designing and Conducting Effective Stability Testing Program Using the Suggested Schedules for Various Product Types

Attendees will gain an understanding in the following key areas:

  • How to Conduct a Pre-approval and Post Approval Stability Testing Studies
  • Performing Various Types of Stability Tests such as Reformulated Products, Accelerated Temperature Studies and others.
  • Understanding the different Types of Stability Test Schedules Provided by Regulations Based on the following Product Types and Information:
    • Suggested Time Points and Expiration dates based on testing time points
    • Solid Dosage Forms Suggested Test Schedule
    • Liquid and Semi-solid Types Products Suggested Test Schedule
    • Reconstituted Products Suggested Test Schedule
    • Performing Different Temperatures of Studies based on the product type such as Room Temperature Studies, Elevated Temperature, Refrigeration, Freezing Temperature and Special Humidity Considerations

12:30 p.m. – 1:30 p.m.


1:30 p.m. – 2:30 p.m.

Session 3
Stability Testing Protocol Design, Data Management, and Trending. Comparative Analysis of Using a Manual versus Automated Data Management

The Attendees will gain an understanding in the following key areas:

  • How to Design an effective Stability Testing Program, Protocol and a Report for a New and Existing Product.
  • How to Effectively Handle, Manage Data, Utilize and Perform the Trending of Stability Testing Results and Data.
  • Using Stability Testing Data to Generate the Product’s Expiration Dating or Shelf Life.
  • How to Perform the Extrapolation of a Product Shelf Life Using Data from an Ongoing Stability Testing Program – Great for products in clinical studies.
  • Understand the different ways of performing statistical analysis of the stability test result data (manual versus automated software).
  • Understand the Advantages and Disadvantages of both systems
  • Key documents to have ready to print out and produce at a moment’s notice

2:30 a.m. – 2:45 p.m.


2:45 p.m. – 3:45 p.m.

Session 4
Analytical Testing Considerations, Review of Case Studies

Attendees will gain an understanding in the following key areas:

  • How to perform Quality Control Testing, Setting Test Specification and Assay Release Process in a Stability Testing Program.
  • Detailed Reasons why the Choice of a Quality Control Test Method, Specific Assays and Tests Specifications are Critical to the Success of a Product’s Stability Testing Program and Shelf Life Determination.
  • Choice of methods with meaningful data or stability indicator
  • Analytical Assay Test Method Attributes
  • Review of Case Studies: Issues Encountered by Drug Product Manufacturers Based on a Poorly Designed Stability Testing Program
    1. Failure to have a written testing program designed to assess the stability characteristics of drug products in order to determine appropriate storage conditions and expirations dates [21 C.F.R. § 211.166(a)].
    2. Failure to have thoroughly investigated any unexplained discrepancy or the failure of a batch or any of its components to meet its specifications whether or not the batch has already been distributed [21 C.F.R. § 211.192].
    3. Failure to ensure your container closure system provided adequate protection against foreseeable external factors in storage and use that can cause deterioration or contamination of the drug product [21 C.F.R. § 211.94(b)].

3:45 p.m. – 4:00 p.m.

Closing Comments and Adjournment